Source-grounded facts extracted from PIPER SANDLER COMPANIES's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
PIPER SANDLER COMPANIES reported first fiscal quarter ended March 31, 2026 results: revenue $474 million, net income $65 million, EPS $0.92.
“On May 1, 2026, Piper Sandler Companies (the "Company") reported its financial results for its first fiscal quarter ended March 31, 2026.”
PIPER SANDLER COMPANIES: Amendment to Certificate of Incorporation to effect a four-for-one forward stock split and increase authorized common stock from 100,000,000 to 400,000,000 shares (effective 2026-03-23).
“On March 23, 2026, Piper Sandler Companies (the “Company”) filed an amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the previously announced four-for-one forward stock split (the “Stock Split”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), without any change to its par value, and to proportionately increase the number of shares of the Company’s authorized Common Stock from 100,000,000 to 400,000,000 in connection with the Stock Split.”
Ann C. Gallo was elected as director at PIPER SANDLER COMPANIES.
“the Board elected Ann C. Gallo to serve as a director of the Company”
PIPER SANDLER COMPANIES reported first fiscal quarter ended March 31, 2024 results: revenue $343, net income $42, EPS $2.43.
“dividends." First Quarter 2024 Results U.S. GAAP Adjusted (1) (Dollars in millions, except per share data) Q1 vs. vs. Q1 vs. vs. 2024 Q4-23 Q1-23 2024 Q4-23 Q1-23 Net revenues $343 -27 % 15 % $334 -27 % 15 % Pre-tax margin 15.3 % -2.9pp 6.6pp 16.8 % -4.9pp 2.7pp Net income attributable to Piper Sandler Companies $42 -18 % 66 % $50 -31 % 18 % Earnings per”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.